BIOMAT Database Logo BIOMAT Database Logo

[Gram negative infections and antibiotic monotherapy]. 1984

J M Ekoe, and L Humair

UI MeSH Term Description Entries
D007275 Injections, Intravenous Injections made into a vein for therapeutic or experimental purposes. Intravenous Injections,Injection, Intravenous,Intravenous Injection
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002435 Cefamandole Semisynthetic wide-spectrum cephalosporin with prolonged action, probably due to beta-lactamase resistance. It is used also as the nafate. Cephamandole,Compound 83405
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D005260 Female Females
D005839 Gentamicins A complex of closely related aminoglycosides obtained from MICROMONOSPORA purpurea and related species. They are broad-spectrum antibiotics, but may cause ear and kidney damage. They act to inhibit PROTEIN BIOSYNTHESIS. Gentamicin Sulfate (USP),Gentamycin,G-Myticin,Garamycin,Gentacycol,Gentamicin,Gentamicin Sulfate,Gentamycins,Gentavet,Genticin,G Myticin,GMyticin,Sulfate, Gentamicin
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

J M Ekoe, and L Humair
Ceftazidime monotherapy vs. ceftriaxone/tobramycin for serious hospital-acquired gram-negative infections. Antibiotic Study Group.
May 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,
J M Ekoe, and L Humair
[Antibiotic treatment of difficult gram-negative infections].
March 1977, Lakartidningen,
J M Ekoe, and L Humair
[Antibiotic therapy for severe gram-negative infections].
January 1983, La Revue du praticien,
J M Ekoe, and L Humair
[Antibiotic therapy of gram negative bacterial infections].
January 1965, Therapie,
J M Ekoe, and L Humair
Combination antibiotic therapy versus monotherapy for gram-negative bacteraemia: a commentary.
January 1999, International journal of antimicrobial agents,
J M Ekoe, and L Humair
Ceftazidime/Avibactam: A New Antibiotic for Gram-Negative Infections.
December 2015, The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists,
J M Ekoe, and L Humair
Single versus combined antibiotic therapy for gram-negative infections.
February 2004, The Annals of pharmacotherapy,
J M Ekoe, and L Humair
Optimal duration of antibiotic treatment in Gram-negative infections.
December 2018, Current opinion in infectious diseases,
J M Ekoe, and L Humair
Real-world antibiotic needs for resistant Gram-negative infections.
October 2020, The Lancet. Infectious diseases,
J M Ekoe, and L Humair
[Aztreonam. A small-spectrum antibiotic in gram-negative infections].
August 1991, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke,
Copied contents to your clipboard!